Literature DB >> 7555196

Making decisions about antithrombotic therapy in heart disease. Decision analytic and cost-effectiveness issues.

M H Eckman1, H J Levine, S G Pauker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7555196     DOI： 10.1378/chest.108.4_supplement.457s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

1.  Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-01       Impact factor: 2.300

Review 2.  Counting the costs of drug-related adverse events.

Authors:  T J White; A Arakelian; J P Rho
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

3.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

4.  Anticoagulation-associated adverse drug events.

Authors:  Gregory Piazza; Thanh Nha Nguyen; Deborah Cios; Matthew Labreche; Benjamin Hohlfelder; John Fanikos; Karen Fiumara; Samuel Z Goldhaber
Journal:  Am J Med       Date:  2011-12       Impact factor: 4.965

5.  Cerebral Sinovenous Thrombosis.

Authors:  Ferdinando S. Buonanno
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.